↓ Skip to main content

American Association for Cancer Research

Article Metrics

Reducing HPV-Associated Cancer Globally

Overview of attention for article published in Cancer Prevention Research, January 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
10 tweeters
patent
2 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
140 Dimensions

Readers on

mendeley
235 Mendeley
Title
Reducing HPV-Associated Cancer Globally
Published in
Cancer Prevention Research, January 2012
DOI 10.1158/1940-6207.capr-11-0542
Pubmed ID
Authors

D. R. Lowy, J. T. Schiller

Abstract

Human papillomavirus (HPV)-related cancers are a major worldwide public health concern. Virtually all cervical cancer is HPV related, with 70% caused by HPV16 and -18. Variable proportions of certain noncervical cancers (e.g., anal, vulvar, and oropharyngeal) are HPV related; more than 90% of the HPV-related ones are caused by HPV16, -18. The HPV-related cancers are dominated by cervical cancer in the developing world, where cervical cancer screening is limited. In this setting, widespread uptake of current HPV vaccines by adolescent girls could reduce this cancer's incidence and mortality by approximately two-thirds, with cost-effective screening programs of adult women having the potential to reduce mortality more rapidly. In the industrialized world, some noncervical HPV-related cancers, especially oropharyngeal, are rapidly increasing, and now rival the incidence of cervical cancer, whose rates continue to decline thanks to established cervical screening programs. Therefore, reducing HPV-associated noncervical cancers with HPV vaccination has greater importance in the industrialized world, especially because there are no approved screening programs for these cancers. Preventing the substantial number of noncervical HPV cancers in men will require either "herd" immunity through high-vaccination rates in females or male vaccination. Current HPV vaccination can complement cervical screening in protecting against cervical cancer and may permit the safe reduction of screening intensity in industrialized countries. Second-generation HPV vaccines (active against a broader array of cervical cancer-related HPV types) could prevent an even higher proportion of cervical precancer and cancer and might permit further reductions in screening intensity.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 235 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
United Kingdom 1 <1%
Portugal 1 <1%
Unknown 230 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 42 18%
Student > Master 42 18%
Student > Ph. D. Student 34 14%
Student > Doctoral Student 23 10%
Researcher 23 10%
Other 37 16%
Unknown 34 14%
Readers by discipline Count As %
Medicine and Dentistry 80 34%
Agricultural and Biological Sciences 38 16%
Biochemistry, Genetics and Molecular Biology 28 12%
Nursing and Health Professions 16 7%
Social Sciences 12 5%
Other 20 9%
Unknown 41 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 37. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 January 2021.
All research outputs
#645,031
of 16,621,802 outputs
Outputs from Cancer Prevention Research
#92
of 1,134 outputs
Outputs of similar age
#3,830
of 128,316 outputs
Outputs of similar age from Cancer Prevention Research
#1
of 37 outputs
Altmetric has tracked 16,621,802 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,134 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 128,316 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.